James Kihara

CIK: 0001816160

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)15 (48.4%)

Position reduction

Option Exercises (M)12 (38.7%)

Derivative conversions

Awards (A)4 (12.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACAD

ACADIA PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

ACAD
ACADIA PHARMACEUTICALS INC
Jun 26, 2026
Sale(S)
Direct
11.4K shares at avg. $26.08$298K
ACAD
ACADIA PHARMACEUTICALS INC
May 26, 2026
Sale(S)
Direct
5.4K shares at avg. $21.18$114K
ACAD
ACADIA PHARMACEUTICALS INC
May 4, 2026
Sale(S)
Direct
1.3K shares at avg. $21.79$29K
ACAD
ACADIA PHARMACEUTICALS INC
May 1, 2026
Exercise(M)
Direct
2.6K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Apr 7, 2026
Sale(S)
Direct
1K shares at avg. $22.20$23K
ACAD
ACADIA PHARMACEUTICALS INC
Apr 5, 2026
Exercise(M)
Direct
2K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Mar 26, 2026
Sale(S)
Direct
1.1K shares at avg. $21.65$24K
ACAD
ACADIA PHARMACEUTICALS INC
Mar 26, 2026
Sale(S)
Direct
12 shares at avg. $21.73$260.704
ACAD
ACADIA PHARMACEUTICALS INC
Mar 25, 2026
Sale(S)
Direct
833 shares at avg. $21.47$18K
ACAD
ACADIA PHARMACEUTICALS INC
Mar 25, 2026
Exercise(M)
Direct
2.1K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Mar 24, 2026
Exercise(M)
Direct
1.6K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Mar 6, 2026
Award(A)
Stock Option (Right to Buy)
Direct
21.8K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Mar 6, 2026
Award(A)
Restricted Stock Units
Direct
6.3K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Nov 18, 2025
Sale(S)
Direct
4.1K shares at avg. $23.69$97K
ACAD
ACADIA PHARMACEUTICALS INC
Nov 17, 2025
Exercise(M)
Direct
4K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Nov 17, 2025
Exercise(M)
Direct
4K shares-
ACAD
ACADIA PHARMACEUTICALS INC
May 16, 2025
Sale(S)
Direct
2K shares at avg. $20.00$40K
ACAD
ACADIA PHARMACEUTICALS INC
May 16, 2025
Sale(S)
Direct
2K shares at avg. $25.00$50K
ACAD
ACADIA PHARMACEUTICALS INC
May 2, 2025
Sale(S)
Direct
1.3K shares at avg. $14.60$19K
ACAD
ACADIA PHARMACEUTICALS INC
May 1, 2025
Exercise(M)
Direct
2.6K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Apr 8, 2025
Sale(S)
Direct
1K shares at avg. $14.82$15K
ACAD
ACADIA PHARMACEUTICALS INC
Apr 5, 2025
Exercise(M)
Direct
2K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Mar 26, 2025
Sale(S)
Direct
1.1K shares at avg. $17.05$19K
ACAD
ACADIA PHARMACEUTICALS INC
Mar 25, 2025
Exercise(M)
Direct
2.1K shares-
ACAD
ACADIA PHARMACEUTICALS INC
Mar 24, 2025
Award(A)
Restricted Stock Units
Direct
6.5K shares-

		Type	Shares	Price		Ownership
Jun 26, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	11,421	$26.08	$297,912	Direct
May 26, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	5,401	$21.18	$114,393	Direct
May 4, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	1,332	$21.79	$29,024	Direct
May 1, 2026	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	2,596	-	$0	Direct
Apr 7, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	1,030	$22.20	$22,866	Direct
Apr 5, 2026	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	2,010	-	$0	Direct
Mar 26, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	1,097	$21.65	$23,750	Direct
Mar 26, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	12	$21.73	$261	Direct
Mar 25, 2026	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	833	$21.47	$17,885	Direct
Mar 25, 2026	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	2,142	-	$0	Direct
Mar 24, 2026	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	1,627	-	$0	Direct
Mar 6, 2026	ACAD ACADIA PHARMACEUTICALS INC	Award(A) Stock Option (Right to Buy)	21,766	-	-	Direct
Mar 6, 2026	ACAD ACADIA PHARMACEUTICALS INC	Award(A) Restricted Stock Units	6,332	-	-	Direct
Nov 18, 2025	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	4,084	$23.69	$96,754	Direct
Nov 17, 2025	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	3,966	-	-	Direct
Nov 17, 2025	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	3,966	-	-	Direct
May 16, 2025	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	2,000	$20.00	$40,000	Direct
May 16, 2025	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	2,000	$25.00	$50,000	Direct
May 2, 2025	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	1,327	$14.60	$19,374	Direct
May 1, 2025	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	2,596	-	-	Direct
Apr 8, 2025	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	1,028	$14.82	$15,235	Direct
Apr 5, 2025	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	2,010	-	-	Direct
Mar 26, 2025	ACAD ACADIA PHARMACEUTICALS INC	Sale(S)	1,095	$17.05	$18,670	Direct
Mar 25, 2025	ACAD ACADIA PHARMACEUTICALS INC	Exercise(M)	2,142	-	-	Direct
Mar 24, 2025	ACAD ACADIA PHARMACEUTICALS INC	Award(A) Restricted Stock Units	6,510	-	-	Direct

1-25 of 31 transactions

About Kihara James

Kihara James (SEC CIK 0001816160) files insider reports with the SEC as PRINCIPAL ACCOUNTING OFFICER of ACADIA PHARMACEUTICALS INC (ACAD).

Signal8 holds 13 ownership filings by Kihara James, all Form 4s, filed between Nov 19, 2024 and Jun 29, 2026. Those filings report 31 transactions, from Nov 17, 2024 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kihara James's filings is in SAN DIEGO, CA.

Recent filings by Kihara James

Jun 26, 2026: Open-market sale of ACAD shares (Form 4, code S).
May 26, 2026: Open-market sale of ACAD shares (Form 4, code S).
May 4, 2026: Open-market sale of ACAD shares (Form 4, code S).
May 1, 2026: Option exercise of ACAD shares (Form 4, code M).
Apr 7, 2026: Open-market sale of ACAD shares (Form 4, code S).

Other insiders filing for ACADIA PHARMACEUTICALS INC (ACAD)

Schneyer Mark C., EVP, CHIEF FINANCIAL OFFICER
Thompson Elizabeth H.Z., EVP, Head of Research & Dev
BAKER BROS. ADVISORS LP, Director
HARRIGAN EDMUND, Director
Ndu Adora, Director
Brege Laura, Director

How to read Form 4 transaction codes